Beyond glue injection: rethinking strategy in gastric variceal bleeding
Endoscopy · 01.06.2026 · 58 (06) · 683
DOI: 10.1055/a-2819-3003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.06.2026. Verfasst von Michael Praktiknjo und 1 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Münster, Department of Medicine B, Germany, Münster.
Abstract (Originalsprache)
Letter to: Aggressive versus conservative endotherapy for gastric varices in cirrhosis: a randomized controlled trial Endoscopy 2026; 58(01): 14-24 DOI: 10.1055/a-2639-1875 10.1055/a-2639-1875 We read with interest the randomized controlled trial (RCT) by Prajapati et al. evaluating aggressive versus conservative cyanoacrylate injection for gastric variceal bleeding (GVB) [ 1 ]. The study showed that additional endoscopic treatment of visually defined non-high-risk varices does not improve clinical outcomes compared with a targeted strategy. However, the more consequential issue may not be the intensity of endoscopic injection, but the overarching therapeutic strategy. More than half of the cohort was Child-Pugh class B or C and a third had massive ascites, characteristics frequently considered when evaluating patients for transjugular intrahepatic portosystemic shunt (TIPS). A recent RCT reported improved rebleeding-free survival with pre-emptive TIPS in acute GVB [ 2 ]. Thus, the Prajapati RCT compares two endoscopic intensities in patients in whom portal hypertension itself remains the dominant prognostic driver and TIPS has been associated with improved outcome [ 2 ], raising the broader question of whether refinement of local therapy is decisive in this setting. Conversely, patients most dependent on optimized endoscopic therapy, particularly those not eligible for TIPS, such as individuals with splanchnic venous thrombosis [ 3 ], were excluded. In these patients, endoscopic management becomes definitive rather than adjunctive, yet the study offers no guidance for this subgroup. Rebleeding risk likely depends less on the extent of surface injection than on complete hemodynamic obliteration. Endohepatologic endoscopic ultrasound-guided approaches allow targeted embolization of feeder vessels using coils and glue, in contrast to injection based solely on surface appearance [ 4 ]. The RCT shows that broader treatment of visually low-risk varices confers no benefit. However, the pivotal decision in many patients is not how intensively to inject, but whether portal hypertension should be addressed, how it should be managed, and in whom endoscopic therapy should serve as definitive care. Advancing care in GVB therefore requires looking beyond the intensity of glue injection toward a personalized strategy integrating portal decompression with endohepatologic approaches. Publication History Article published online: 21 May 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Autor:innen und Institutionen
- University Hospital Münster, Department of Medicine B, Germany, Münster.
- Hôpital Rangueil, CHU Toulouse, and Université de Toulouse, Service d'Hépatologie, France, Toulouse.
ORCID-Profile: Michael Praktiknjo
Zitieren
APA
Praktiknjo, M., & Bureau, C. (2026). Beyond glue injection: rethinking strategy in gastric variceal bleeding. Endoscopy, 58(06), 683. https://doi.org/10.1055/a-2819-3003
Vancouver
Praktiknjo M, Bureau C. Beyond glue injection: rethinking strategy in gastric variceal bleeding. Endoscopy. 2026;58(06):683. doi:10.1055/a-2819-3003
BibTeX
@article{Praktiknjo2026,
author = {Praktiknjo, Michael and Bureau, Christophe},
title = {Beyond glue injection: rethinking strategy in gastric variceal bleeding},
journal = {Endoscopy},
year = {2026},
volume = {58},
number = {06},
pages = {683},
doi = {10.1055/a-2819-3003}
}
EUVIMED